RUNX1 and breast carcinoma: The expression of key markers associated with proliferation (MKI67, PCNA, CCNB1, MYBL2, BUB1, CCND1), apoptosis (BCL2, CASP7, CASP8, CASP9, CASP3, BAX, APAF1), differentiation (CDH1, CD24, EPCAM, ESR1, NGFR, RUNX1), and breast cancer stemness (CD44, ITGA6, DNER, ALDH1A3, ABCG2, PROCR) was assessed.